4.5 Article

Molecular Simulations Indicate Marked Differences in the Structure of Amylin Mutants, Correlated with Known Aggregation Propensity

Journal

JOURNAL OF PHYSICAL CHEMISTRY B
Volume 117, Issue 50, Pages 16066-16075

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jp409755y

Keywords

-

Funding

  1. National Science Foundation [CBET-1120399, MCB-120014]

Ask authors/readers for more resources

Human islet amyloid polypeptide (hIAPP), a 37-residue protein cosecreted with insulin by beta-cells in the pancreas, is known to form amyloid fibrils in type II diabetes patients. This fibril formation is also associated with beta-cell death. However, rat IAPP (rIAPP) does not aggregate into fibrils, nor is it associated with beta-cell toxicity. Determining solution properties of hIAPP experimentally is difficult because it aggregates quickly. Our study uses molecular dynamics simulation to explore and compare in-solution characteristics of hIAPP and rIAPP, as well as two single-point hIAPP mutants, hIAPP I26P and hIAPP S20G, which exhibit observed differences from hIAPP in aggregation propensities. We find that all four polypeptide monomers sample structured states in solution. More importantly, differences in the helicity over residues 7-16 may play an important role in early aggregation, although this region is outside of commonly assumed amyloidogenic region 20-29. The long-range contacts, though unexpected of IDPs, cause variation in sampled conformations among four polypeptides within same amino acid sequence. Our results also yield evidence that previously determined structures bound to micelles are also transiently sampled in the solution state. In particular, similarities found in region 8-17 together with the helical differences that we observe in region 7-16 lead us to suggest that the region 7-16 is potentially responsible for amyloidogenic behavior of amylin peptides. Our results also provide support for the proposed mechanism of fibril formation based on experimentally observed transient helices in amyloidogenic peptides.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available